CombiGene AB (publ)

CombiGene AB (publ)verified

COMBI.ST

Price:

$2.47

Market Cap:

$48.91M

CombiGene AB (publ) engages in the development of gene therapy for severe life-altering diseases in Sweden. The company is developing two gene therapy candidates, including CG01, which is in preclinical studies for the treatment of epilepsy and biodistribution and toxicology studies; and CGT2 for the treatment of lipodystrophy. The company has a licensing and collaboration agreement with Lipigon Pharmaceuticals AB to develop a gene therapy treatment for partial lipodystrophy; and with Spark Therapeutics to develop adeno-associated virus (AAV) based gene therapies. CombiGene AB (publ) was founded in 1999 and is headquartered in Lidingö, Sweden.

Industry

Biotechnology

IPO Date

2015-05-25

Stock Exchange

STO

Ticker

COMBI.ST

The Enterprise Value as of December 2025 (TTM) for CombiGene AB (publ) (COMBI.ST) is -24839036.00

According to CombiGene AB (publ)’s latest financial reports and current stock price. The company's current Enterprise Value is -24839036.00. This represents a change of 9.36% compared to the average of -22712552.50 of the last 4 quarters.

CombiGene AB (publ) (COMBI.ST) Historical Enterprise Value (quarterly & annually)

How has COMBI.ST Enterprise Value performed in the past?

The mean historical Enterprise Value of CombiGene AB (publ) over the last ten years is 37.55M. The current -24839036.00 Enterprise Value has changed -6714.69% with respect to the historical average. Over the past ten years (40 quarters), COMBI.ST's Enterprise Value was at its highest in in the December 2015 quarter at 111.30M. The Enterprise Value was at its lowest in in the December 2023 quarter at -48175310.00.

Quarterly (TTM)
Annual

Average

37.55M

Median

53.83M

Minimum

-48175065.00

Maximum

102.69M

CombiGene AB (publ) (COMBI.ST) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of CombiGene AB (publ) Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 477.29%

Maximum Annual Enterprise Value = 102.69M

Minimum Annual Increase = -197.91%

Minimum Annual Enterprise Value = -48175065.00

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024-26621620.00-44.74%
2023-48175065.00-197.91%
202249.20M-18.81%
202160.60M-21.26%
202076.96M31.64%
201958.46M477.29%
201810.13M-26.13%
201713.71M-82.55%
201678.56M-23.50%
2015102.69M42.64%

CombiGene AB (publ) (COMBI.ST) Average Enterprise Value

How has COMBI.ST Enterprise Value performed in the past?

The current Enterprise Value of CombiGene AB (publ) (COMBI.ST) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-8531000.00

5-year avg

22.39M

10-year avg

37.55M

CombiGene AB (publ) (COMBI.ST) Enterprise Value vs. Peers

How is COMBI.ST’s Enterprise Value compared to its peers?

CombiGene AB (publ)’s Enterprise Value is less than FRISQ Holding AB (publ) (118.85M), less than Kancera AB (publ) (8.45M), less than Emplicure AB (publ) (33.32M), less than RLS Global AB (publ) (15.17M), less than Amniotics AB (publ) (9.13M), less than Idogen AB (publ) (7.48M), less than Pharmiva AB (publ) (-1197289.00), less than Cline Scientific AB (publ) (570.35K), less than Diagonal Bio AB (publ) (17.46M), less than Ziccum AB (publ) (7.88M),

Build a custom stock screener for CombiGene AB (publ) (COMBI.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CombiGene AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

CombiGene AB (publ) (COMBI.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like CombiGene AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is CombiGene AB (publ)'s Enterprise Value?

What is the highest Enterprise Value for CombiGene AB (publ) (COMBI.ST)?

What is the 3-year average Enterprise Value for CombiGene AB (publ) (COMBI.ST)?

What is the 5-year average Enterprise Value for CombiGene AB (publ) (COMBI.ST)?

How does the current Enterprise Value for CombiGene AB (publ) (COMBI.ST) compare to its historical average?